US 9018380
Heterocyclic modulators of HIF activity for treatment of disease
granted A61KA61K31/4245A61K31/427
Quick answer
US patent 9018380 (Heterocyclic modulators of HIF activity for treatment of disease) held by Boards of Regents, The University of Texas System expires Mon Apr 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Boards of Regents, The University of Texas System
- Grant date
- Tue Apr 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K31/4245, A61K31/427, A61K31/437, A61K31/4439